The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013

Journal of Infection and Chemotherapy

Volumn 21, Issue 5, 2015, Pages 340-345

  Hamasuna, Ryoichi ^a,c   Yasuda, Mitsuru ^a,d   Ishikawa, Kiyohito ^a,e   Uehara, Shinya ^a,f   Hayami, Hiroshi ^a,g   Takahashi, Satoshi ^a,h   Matsumoto, Tetsuro ^a,c   Yamamoto, Shingo ^a,i   Minamitani, Shinichi ^a   Watanabe, Akira ^b   Iwata, Satoshi ^b   Kaku, Mitsuo ^b   Kadota, Junichi ^b   Sunakawa, Keisuke ^b   Sato, Junko ^b   Hanaki, Hideaki ^j   Tsukamoto, Taiji ^h   Kiyota, Hiroshi ^k   Egawa, Shin ^l   Tanaka, Kazushi ^m   Arakawa, Soichi ^m   Fujisawa, Masato ^m   Kumon, Hiromi ^f   Kobayashi, Kanao ⁿ   Matsubara, Akio ⁿ   Naito, Seiji ^o   Kuroiwa, Kentaro ^o   Hirayama, Hideo ^p   Narita, Harunori ^q   Hosobe, Takahide ^r   Ito, Shin ^s   Ito, Kenji ^t   Kawai, Shuichi ^u   Ito, Masayasu ^v   Chokyu, Hirofumi ^w   Matsumura, Masaru ^x   Yoshioka, Masaru ^y   Uno, Satoshi ^z   Monden, Koichi ^aa   Takayama, Kazuo ^ab   Kaji, Shinichi ^ac   Kawahara, Motoshi ^ad   Sumii, Toru ^ae   Kadena, Hitoshi ^af   Yamaguchi, Takamasa ^ag   Maeda, Shinichi ^ah   Nishi, Shohei ^ai   Nishimura, Hirofumi ^aj   Shirane, Takeshi ^ak   Yoh, Mutsumasa ^al   Akiyama, Kikuo ^am   Imai, Toshio ^an   Kano, Motonori ^ao   more..

^a Japanese Association for Infectious Diseases (JAID)   (Japan)

^b Surveillance Committee of JSC JAID and JSCM   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^d GIFU UNIVERSITY HOSPITAL   (Japan)

^e FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f OKAYAMA UNIVERSITY   (Japan)

^g KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^h SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ HYOGO COLLEGE OF MEDICINE   (Japan)

^j KITASATO UNIVERSITY   (Japan)

^k Jikei University School of Medicine   (Japan)

^l JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^m KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁿ HIROSHIMA UNIVERSITY   (Japan)

^o KYUSHU UNIVERSITY   (Japan)

^p Hirayama Urological Clinic   (Japan)

^q Narita Clinic   (Japan)

^r Hosobe Clinic   (Japan)

^s IClinic   (Japan)

^t Ito Urology Clinic   (Japan)

^u Kawai Urology Clinic   (Japan)

^v Gifu Urology Clinic   (Japan)

^w Chokyu Tenma Clinic   (Japan)

^x Matsumura Urology Clinic   (Japan)

^y Yoshioka Urological Clinic   (Japan)

^z Hirajima Clinic   (Japan)

^aa Araki Urological Clinic   (Japan)

^ab Takayama Hospital   (Japan)

^ac Kaji Clinic   (Japan)

^ad Kawahara Urology Clinic   (Japan)

^ae Sumii Clinic   (Japan)

^af Kadena Urological Clinic   (Japan)

^ag Yamaguchi Dermatology and Urology Clinic   (Japan)

^ah TOYOTA MEMORIAL HOSPITAL   (Japan)

^ai Nishi Urology and Dermatology Clinic   (Japan)

^aj Nishimura Urology Clinic   (Japan)

^ak Shirane Urology Clinic   (Japan)

^al Yoh Urology and Dermatology Clinic   (Japan)

^am Akiyama Urological Clinic   (Japan)

^an Imai Urological Clinic   (Japan)

^ao Kano Hospital   (Japan)

more..

Author keywords

2012; 2013; Antimicrobial susceptibilities; Japan; Nationwide surveillance; Neisseria gonorrhoeae

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; AZTREONAM; BETA LACTAMASE; CEFDINIR; CEFDITOREN; CEFIXIME; CEFODIZIME; CEFPODOXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; FLOMOXEF; LEVOFLOXACIN; MACROLIDE; MEROPENEM; MINOCYCLINE; PENICILLIN DERIVATIVE; PENICILLIN G; QUINOLONE DERIVATIVE; SITAFLOXACIN; SPECTINOMYCIN; TOSUFLOXACIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; DISEASE SURVEILLANCE; GONOCOCCAL URETHRITIS; GONORRHEA; HUMAN; JAPAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; URETHRAL DISCHARGE; URETHRAL PAIN; URETHRITIS; ADOLESCENT; DRUG EFFECTS; HEALTH SURVEY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; JAPAN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEISSERIA GONORRHOEAE; PENICILLINS; POPULATION SURVEILLANCE; URETHRITIS; YOUNG ADULT;

EID: 84933049453     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2015.01.010     Document Type: Article

References (24)

1. Hamasuna R., Yasuda M., Ishikawa K., Uehara S., Takahashi S., Hayami H., et al. Nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan. JInfect Chemother 2013, 19:571-578.
2. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement M100-S22 2012, CLSI, PA, USA.
3. Ohnishi M., Saika T., Hoshina S., Iwasaku K., Nakayama S., Watanabe H., et al. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg Infect Dis 2011, 17:148-149.
4. Unemo M., Golparian D., Nicholas R., Ohnishi M., Gallay A., Sednaoui P. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 2012, 56:1273-1280.
5. Camara J., Serra J., Ayats J., Bastida T., Carnicer-Pont D., Andreu A., et al. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. JAntimicrob Chemother 2012, 67:1858-1860.
6. Shimuta K., Unemo M., Nakayama S., Morita-Ishihara T., Dorin M., Kawahata T., et al. Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. Antimicrob Agents Chemother 2013, 57:5225-5232.
7. Chisholm S.A., Dave J., Ison C.A. High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes. Antimicrob Agents Chemother 2010, 54:3812-3816.
8. Galarza P.G., Abad R., Canigia L.F., Buscemi L., Pagano I., Oviedo C., et al. New mutation in 23S rRNA gene associated with high level of azithromycin resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2010, 54:1652-1653.
9. Katz A.R., Komeya A.Y., Soge O.O., Kiaha M.I., Lee M.V., Wasserman G.M., et al. Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States. Clin Infect Dis 2012, 54:841-843.
10. Unemo M., Golparian D., Hellmark B. First three Neisseria gonorrhoeae isolates with high-level resistance to azithromycin in Sweden: a threat to currently available dual-antimicrobial regimens for treatment of gonorrhea?. Antimicrob Agents Chemother 2014, 58:624-625.
11. Palmer H.M., Young H., Winter A., Dave J. Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland. JAntimicrob Chemother 2008, 62:490-494.
12. Japanese Society of Sexually Transmitted Infection Gonococcal infection. Sexually transmitted infections, diagnosis and treatment guidelines 2011. Jpn J Sex Transm Dis 2011, 22:52-59. (in Japanese).
13. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO western pacific and south east Asian regions, 2009. Commun Dis Intell 2011, 35:2-7.
14. Unemo M., Golparian D., Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill 2011, 16.
15. Unemo M., Golparian D., Potocnik M., Jeverica S. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Euro Surveill 2012, 17.
16. YC M., Stevens K., Tideman R., Zaia A., Tomita T., Fairley C.K., et al. Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia. JAntimicrob Chemother 2013, 68:1445-1447.
17. Read P.J., Limnios E.A., McNulty A., Whiley D., Lahra M.M. One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500mg ceftriaxone in Sydney, Australia. Sex Health 2013, 10:460-462.
18. Deguchi T., Yasuda M., Yokoi S., Ishida K., Ito M., Ishihara S., et al. Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval. JInfect Chemother 2003, 9:35-39.
19. Ohnishi M., Golparian D., Shimuta K., Saika T., Hoshina S., Iwasaku K., et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011, 55:3538-3545.
20. Unemo M., Shafer W.M. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev 2014, 27:587-613.
21. Tanaka M., Nakayama H., Notomi T., Irie S., Tsunoda Y., Okadome A., et al. Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993-2002: continuous increasing of ciprofloxacin-resistant isolates. Int J Antimicrob Agents 2004, 1:S15-S22.
22. Takayama Y., Nakayama S., Shimuta K., Morita-Ishihara T., Ohnishi M. Characterization of azithromycin-resistant Neisseria gonorrhoeae isolated in Tokyo in 2005-2011. JInfect Chemother 2014, 20:339-341.
23. Yasuda M., Ito S., Kido A., Hamano K., Uchijima Y., Uwatoko N., et al. Asingle 2 g oral dose of extended-release azithromycin for treatment of gonococcal urethritis. JAntimicrob Chemother 2015, 69:3116-3118.
24. Tapsall J.W., Ndowa F., Lewis D.A., Unemo M. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther 2009, 7:821-834.